An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women
Clinical trial NCT01796301 · COMPLETED
Trial details
- NCT number
- NCT01796301
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-31
- Primary completion
- 2015-05-14
- Enrollment
- 436
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.